In April 2011, the drug Lipostabil, whose active ingredient is phosphatidylcholine, used to reduce fats located in cosmetic procedures, was banned in Brazil by Anvisa (National Health Surveillance Agency). Anvisa still wants to regulate and restrict the use of this substance.
Anvisa warns everyone that the use of this drug has not yet been authorized in Brazil due to the lack of scientific research related to indications and long-term adverse effects that may occur with its use, and that localized fat reduction is not scientifically proven.
- Lipostabil is distributed by Aventis Pharma’s laboratory in Italy and according to Anvisa any company marketing the product will be evaluated and may receive fines and.
- In extreme cases.
- The property can be closed.